ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
CBRE Global Real Estate Income Fund

CBRE Global Real Estate Income Fund (IGR)

5.01
-0.04
(-0.79%)
At close: June 20 4:00PM
4.97
-0.035
( -0.70% )
After Hours: 5:47PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.97
Bid
-
Ask
-
Volume
492,429
4.96 Day's Range 5.02
3.88 52 Week Range 5.62
Market Cap
Previous Close
5.05
Open
4.96
Last Trade
3207
@
5.01
Last Trade Time
19:00:00
Financial Volume
$ 2,456,542
VWAP
4.9886
Average Volume (3m)
476,704
Shares Outstanding
139,968,594
Dividend Yield
14.49%
PE Ratio
6.24
Earnings Per Share (EPS)
0.8
Revenue
43.08M
Net Profit
112.14M

About CBRE Global Real Estate Income Fund

CBRE Clarion Global Real Estate Income Fund is a United States based diversified, closed-end management investment company. CBRE Clarion Global Real Estate Income Fund is a United States based diversified, closed-end management investment company.

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Wilmington, Delaware, USA
Founded
1970
CBRE Global Real Estate Income Fund is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker IGR. The last closing price for CBRE Global Real Estate ... was $5.05. Over the last year, CBRE Global Real Estate ... shares have traded in a share price range of $ 3.88 to $ 5.62.

CBRE Global Real Estate ... currently has 139,968,594 shares outstanding. The market capitalization of CBRE Global Real Estate ... is $699.84 million. CBRE Global Real Estate ... has a price to earnings ratio (PE ratio) of 6.24.

IGR Latest News

CORRECTING and REPLACING CBRE Global Real Estate Income Fund (NYSE: IGR) Declares Monthly Distribution for April, May and June and Announces a Webinar with Portfolio Management

In the first table of release dated April 8, 2024, the June 2024 Ex-Dividend Date should read: 06-20-2024 (instead of 06-18-2024). The updated release reads: CBRE GLOBAL REAL ESTATE INCOME FUND...

CBRE Global Real Estate Income Fund (NYSE: IGR) Declares Monthly Distribution for April, May and June and Announces a Webinar with Portfolio Management

The Board of Trustees of the CBRE Global Real Estate Income Fund (NYSE: IGR) (the “Fund”) has declared three distributions of $0.06 per share for the months of April, May and June 2024 ($0.18 per...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.13-2.549019607845.15.164.963243975.06738201CS
4-0.12-2.357563850695.095.214.85494100025.02698134CS
12-0.33-6.226415094345.35.4054.684767045.03070306CS
26-0.33-6.226415094345.35.564.686192915.17552419CS
52-0.38-7.102803738325.355.623.886315714.99073266CS
156-3.74-42.93915040188.719.893.884806586.1671678CS
260-2.65-34.77690288717.629.893.52714502856.39254137CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPECSpectaire Holdings Inc
$ 0.8669
(154.97%)
7.6M
SRPTSarepta Therapeutics Inc New
$ 168.15
(36.15%)
846.34k
BRNSBarinthus Biotherapeutics PLC
$ 1.51
(20.80%)
3.12k
KTRAKintara Therapeutics Inc
$ 0.3208
(16.70%)
11.92M
LGHLWLion Group Holding Ltd
$ 0.0075
(15.38%)
21.05k
RELIReliance Global Group Inc
$ 0.511
(-15.38%)
1.92M
PBMPsyence Biomedical Ltd
$ 0.52
(-13.33%)
8.85M
SMXSMX Security Matters Public Company
$ 0.1447
(-10.01%)
2.18M
LDTCLeddarTech Holdings Inc
$ 0.874
(-8.58%)
500
VMARVision Marine Technologies Inc
$ 0.58
(-8.08%)
88.02k
ZCARZoomcar Holdings Inc
$ 0.166999
(14.23%)
13.47M
KTRAKintara Therapeutics Inc
$ 0.3208
(16.70%)
11.92M
NVDANVIDIA Corporation
$ 130.18
(-0.46%)
11.66M
PBMPsyence Biomedical Ltd
$ 0.55
(-8.33%)
8.81M
SPECSpectaire Holdings Inc
$ 0.8669
(154.97%)
7.6M

Discussion

View Full Feed
getmoreshares getmoreshares 2 minutes ago
no--our ceo is Logan Rice
CGAC
Dubster watching Dubster watching 2 minutes ago
Lovely, and healthy in extended
UVIX
valuetrap valuetrap 3 minutes ago
Price predictions after debate next week?
tschussmann1 tschussmann1 3 minutes ago
On the other hand, Dr Missling had said that he was looking for innovative solutions (my words) to commercializing an approved drug, so maybe something different than traditional big Pharma? Maybe separate contracts with mfg, distribution, and marketing?
AVXL
boston745 boston745 3 minutes ago
To add to my post about NP Aerospace, here is this part from Tuesdays Press Release.

Other proprietary technologies include the manufacture of high performance, lower cost ballistic materials for opaque armor applications at its subsidiary, SINTX Armor. SINTX Armor is expected to begi
SINT
StockInfo11 StockInfo11 3 minutes ago
Yesterday, Prismo Metals Inc. (PRIZ.c PMOMF) raised ~$1.145M to fund drilling programs at its Palos Verdes silver project in Mexico and Hot Breccia copper project in Arizona's copper belt. The projects aim to uncover significant mineral resources, with plans to drill 3,600m at Palos Verdes and 1,000
PMOMF
PennyStockTrader2 PennyStockTrader2 4 minutes ago
Im going to pick up another 150K+ down at .009 if possible, its an easy 30% gain, for starters, from here.
CVAT
zakattack zakattack 4 minutes ago
Better happen tomm
PSRU
The GidDy uP Kid The GidDy uP Kid 4 minutes ago
TPHS .23sss
TPHS
capgain capgain 4 minutes ago
Good to hear, carry on!
KILLAZILLA KILLAZILLA 4 minutes ago
IT'S CALLED DILUTION.....!!!!!!!!!

LYING GRIFTERS SCAMMING NAIVE RETAIL......!!!!!!!!

WAKE UP!!!!!!
XERI
AD4NO AD4NO 4 minutes ago
Huge major short squeeze coming that will blow your minds. I mean stock moving not only to pennies but hit dollars coming up!!
CATV
StockInfo11 StockInfo11 5 minutes ago
Temas Resources' La Blache Project in Quebec is set to enhance North America's titanium supply amid a crisis of counterfeit titanium affecting Boeing and Airbus. With strong economic potential and proprietary processing technology, it aims to provide a reliable, high-quality titanium source for crit
TMASF
NASDAQ2020 NASDAQ2020 5 minutes ago
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for pati
ELTP
delerious1 delerious1 5 minutes ago
My take on it is that RONN would be better off chasing the Infrastructure end of things for now such as building ReFueling stations and perhaps Trucking services to supply the "gas" stations using Hydrogen powered trucks , eventually,... to supply the "gas stations".....and the Car or SUV (the Mysti
RONN
Carjockey2 Carjockey2 5 minutes ago
https://x.com/FAa172830479777/status/1803925649507152239?t=3ssiKmhQ03HfaHZ36Lsv9g&s=19
FSRNQ
georgie18 georgie18 5 minutes ago
Have no idea...that was a long time ago...🥳
IJJP
XenaLives XenaLives 5 minutes ago
oops
AVXL
havnagoodtime havnagoodtime 6 minutes ago
Train, how crazy is this? >> If anyone goes to the website and reads Dr. Joe Catalino's resume, they would be like "Why isn't Dr. Catalino in charge of meetings, especially involving the U.S. Navy?" Instead, Dennis will give a presentation, stuttering and stammering his way throughout. He thinks he'
DPLS
prototype_101 prototype_101 6 minutes ago
PECC October 22-23 Optica Photonic-Enabled Cloud Computing Industry Summit hosted by Synopsys has a TOP SHELF speaker list, check it out here

https://www.optica.org/events/industry_events/2024/pecc/program_speakers/

Investors keep in mind that Synopsys has been posting
LWLG
girlfriend girlfriend 6 minutes ago
Yeah miserable chart.
SOFI
gfp927z gfp927z 7 minutes ago
>>> Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug


Bloomberg

by Gerry Smith

Jun 20, 2024


https://finance.yahoo.com/news/sarepta-jumps-broad-approval-muscular-220459501.html


(Bloomberg) --
jaramill jaramill 7 minutes ago
$HHSE NEWS: MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

Link to Minutes --> https://www.otcmarkets.com/otcapi/company/financial-report/405767/content MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

HANNOVER HOUSE, INC.


HHSE
NASDAQ2020 NASDAQ2020 7 minutes ago
https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
theorysuit theorysuit 8 minutes ago
Why would you look back. They need reimbursement to even sell this and no one knows what kind of revenue split they have with advent. There is no path to profitability in the UK. Let the dilution continue for perpetuity. This is a piggy bank/ATM for LP and cronies. ADVENT and annual salari
NWBO

Your Recent History

Delayed Upgrade Clock